EUCTR2010-019635-36-IS进行中（未招募）不适用
A Single Centre, Open-Label, Randomised Multi-Dose Study to Assess Changes in the Brain Metabolism of Juvenile ADHD Patients After Thirteen Weeks of Daily Intake of 4 g Superba Krill Oil or 4 g omega-3 Enriched Fish Oil
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •All participants are male ADHD patients of the combined type and are of age 7-11 years.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Known allergy to crustacean or fish
研究者
相似试验
尚未招募
不适用
A Bioequivalence Study of Ferric Carboxymaltose Intravenous Injection in Adult Patients with Iron Deficiency AnaemiaCTRI/2021/08/036072Dr Reddys Laboratories Ltd
已完成
不适用
The is a study which is Multicentric, Parallel Arm Bioequivalence Study of Ferric Carboxymaltose Intravenous Injection (750 mg Iron/15 mL) of Dr. Reddy’s Laboratories Ltd, India, with that of Injectafer® of American Regent Inc USA Under Fasting Condition in Adult Patients.CTRI/2023/08/056038Dr. Reddy’s Laboratories Limited120
已完成
不适用
A multi-center, single-dose, open-label, randomized, parallel group study to investigate the reduction of initial taspoglutide Cmax after administration of 20 mg taspoglutide 10% Sustained Release Formulation (SRF) using three modified formulations as compared to the current Phase 3 formulation in healthy volunteers.diabetes mellitus type 210018424diabetesNL-OMON34034Hoffmann-La Roche100
已完成
不适用
Comparison of two Imatinib Mesylate tablets in patients of Philadelphia chromosome positive Chronic Myeloid Leukaemia stabilized on Imatinib Mesylate tablets 400mgCTRI/2013/07/003836Ranbaxy Laboratories Limited42
进行中（未招募）
1 期
A study of XOMA 213 in the reduction of breast milk production in women after child birth.Suppression of Lactation after Delivery in Postpartum WomenEUCTR2015-005751-27-ESXOMA (US) LLC